[HTML][HTML] Quadrupole time-of-flight mass spectrometry: a paradigm shift in toxicology screening applications

DR Allen, BC McWhinney - The Clinical Biochemist Reviews, 2019 - ncbi.nlm.nih.gov
The screening of biological samples for the presence of illicit or legal substances is an
important frontline tool in both clinical and forensic toxicology. In the clinical setting, drug …

Advances in drugs of abuse testing

K Tamama - Clinica Chimica Acta, 2021 - Elsevier
Drugs of abuse testing is widely used clinically and forensically. Urine is the preferred type
of specimen for drugs of abuse screening, but saliva, sweat, hair, and meconium are …

Laboratory testing for prescription opioids

MC Milone - Journal of medical toxicology, 2012 - Springer
Opioid analgesic misuse has risen significantly over the past two decades, and these drugs
now represent the most commonly abused class of prescription medications. They are a …

A high-throughput ion mobility spectrometry–mass spectrometry screening method for opioid profiling

KE Butler, ES Baker - Journal of the American Society for Mass …, 2022 - ACS Publications
In 2017, the United States Department of Health and Human Services declared the
widespread misuse and abuse of prescription and illicit opioids an epidemic. However, this …

LC-MS-MS vs ELISA: validation of a comprehensive urine toxicology screen by LC-MS-MS and a comparison of 100 forensic specimens

KW Kahl, JZ Seither, LJ Reidy - Journal of analytical toxicology, 2019 - academic.oup.com
Toxicology laboratories commonly employ immunoassay methodologies to perform an initial
drug screen on urine specimens to direct confirmatory testing. Due to limitations of …

The utility of immunoassays for urine drug testing

SEF Melanson - Clinics in laboratory medicine, 2012 - Elsevier
Substance abuse is a significant problem in the United States. 1 Over 2.1 million emergency
department visits in 2009 were associated with drug misuse or abuse, of which 47 …

Does urine drug abuse screening help for managing patients? A systematic review

J Dupouy, V Memier, H Catala, M Lavit, S Oustric… - Drug and Alcohol …, 2014 - Elsevier
Background In the field of addiction, assessment of psychoactive substance use is a key
element. Nevertheless, self-reports and clinical examination underestimate the use of …

Screening with quantification for 64 drugs and metabolites in human urine using UPLC–MS-MS analysis and a threshold accurate calibration

TG Rosano, PY Ohouo, M Wood - Journal of analytical …, 2017 - academic.oup.com
Drug and metabolite (analytes) identification together with quantification is an important
analytical tool in forensic and clinical toxicology. We report the development and validation …

Interpretation and utility of drug of abuse screening immunoassays: insights from laboratory drug testing proficiency surveys

MD Krasowski, GA McMillin… - … of Pathology & …, 2020 - meridian.allenpress.com
Context.—Urine drug testing is frequently ordered by health care providers. Immunoassays
are widely used for drug testing, yet have potential limitations, including variable cross …

A difficult challenge for the clinical laboratory: accessing and interpreting manufacturer cross-reactivity data for immunoassays used in urine drug testing

JM Reschly-Krasowski… - Academic pathology, 2018 - journals.sagepub.com
Urine drug testing by immunoassay is widely used to detect nonmedical drug use and to
monitor patients prescribed controlled substances. A key attribute of urine drug testing …